Go to www.buffalo.edu/news for the latest in campus news and reports.
Professor Troy D. Wood
A nanotechnology developed by Troy D. Wood, UB associate professor of chemistry, has enabled researchers to identify a molecular signature common to both familial and sporadic cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.
It is the first time that a common molecular signature has been found in patients with both familial and sporadic cases, where no other family members have ALS. The finding reveals that a peptide found in a gene in spinal cord fluid is common to patients with the disease.
The work was done through a collaboration of UB chemists with scientists studying ALS at California Pacific Medical Center Research Institute, Johns Hopkins University, University of California at San Diego and University of Pittsburgh.